These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 31958478)

  • 61. Prediction for cardiovascular diseases based on laboratory data: An analysis of random forest model.
    Su X; Xu Y; Tan Z; Wang X; Yang P; Su Y; Jiang Y; Qin S; Shang L
    J Clin Lab Anal; 2020 Sep; 34(9):e23421. PubMed ID: 32725839
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Longitudinal association between cardiovascular risk factors and depression in young people: a systematic review and meta-analysis of cohort studies.
    Chaplin AB; Daniels NF; Ples D; Anderson RZ; Gregory-Jones A; Jones PB; Khandaker GM
    Psychol Med; 2023 Feb; 53(3):1049-1059. PubMed ID: 34167604
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Cardiovascular risk factor mediation of the effects of education and Genetic Risk Score on cardiovascular disease: a prospective observational cohort study of the Framingham Heart Study.
    Powell KL; Stephens SR; Stephens AS
    BMJ Open; 2021 Jan; 11(1):e045210. PubMed ID: 33436477
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Joint longitudinal and time-to-event modelling compared with standard Cox modelling in patients with type 2 diabetes with and without established cardiovascular disease: An analysis of the EXSCEL trial.
    Oulhaj A; Aziz F; Suliman A; Iqbal N; Coleman RL; Holman RR; Sourij H
    Diabetes Obes Metab; 2023 May; 25(5):1261-1270. PubMed ID: 36635232
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Association Between Cardiovascular Risk and Perceived Fatigability in Mid-to-Late Life.
    Qiao Y; Martinez-Amezcua P; Wanigatunga AA; Urbanek JK; Simonsick EM; Ferrucci L; Schrack JA
    J Am Heart Assoc; 2019 Aug; 8(16):e013049. PubMed ID: 31409206
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The age-specific quantitative effects of metabolic risk factors on cardiovascular diseases and diabetes: a pooled analysis.
    Singh GM; Danaei G; Farzadfar F; Stevens GA; Woodward M; Wormser D; Kaptoge S; Whitlock G; Qiao Q; Lewington S; Di Angelantonio E; Vander Hoorn S; Lawes CM; Ali MK; Mozaffarian D; Ezzati M; ; ; ;
    PLoS One; 2013; 8(7):e65174. PubMed ID: 23935815
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Web-based self-assessment health tools: who are the users and what is the impact of missing input information?
    Neufingerl N; Cobain MR; Newson RS
    J Med Internet Res; 2014 Sep; 16(9):e215. PubMed ID: 25261155
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Better risk assessment with glycated hemoglobin instead of cholesterol in CVD risk prediction charts.
    Faeh D; Rohrmann S; Braun J
    Eur J Epidemiol; 2013 Jul; 28(7):551-5. PubMed ID: 23860709
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Evaluation of Ischemic Heart Disease Factors in Hemophilia Patients in Khorramabad.
    Nezami A; Tarhani F; Elahi S
    Cardiovasc Hematol Disord Drug Targets; 2020; 20(4):284-288. PubMed ID: 33256585
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Blood pressure and pulse responses to three stressors: associations with sociodemographic characteristics and cardiovascular risk factors.
    Rose KM; North K; Arnett DK; Ellison RC; Hunt SC; Lewis CE; Tyroler HA
    J Hum Hypertens; 2004 May; 18(5):333-41. PubMed ID: 14739908
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Relationship of cardiovascular disease risk and hearing loss in a clinical population.
    Baiduc RR; Sun JW; Berry CM; Anderson M; Vance EA
    Sci Rep; 2023 Jan; 13(1):1642. PubMed ID: 36717643
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Cardiovascular risk management in people with type 1 diabetes: performance using three guidelines.
    Varkevisser RDM; Birnie E; Vollenbrock CE; Mul D; van Dijk PR; van der Klauw MM; Veeze H; Wolffenbuttel BHR; Aanstoot HJ
    BMJ Open Diabetes Res Care; 2022 Jul; 10(4):. PubMed ID: 35858715
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cardiovascular risk in the elderly population of Spain. The EPICARDIAN risk score.
    Gabriel R; Muñiz J; Vega S; Moral I; Pérez Castro TR; Rodriguez-Salvanés F; Suárez C; Novella B; Brotons C;
    Rev Clin Esp (Barc); 2022 Jan; 222(1):13-21. PubMed ID: 34565710
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Psychosocial stressors predict lower cardiovascular disease risk among Mexican-American adults living in a high-risk community: Findings from the Texas City Stress and Health Study.
    Hussain M; Howell JL; Peek MK; Stowe RP; Zawadzki MJ
    PLoS One; 2021; 16(10):e0257940. PubMed ID: 34618834
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Cardiovascular risk profiles in German Air Force pilots.
    Sammito S; Güttler N
    BMJ Mil Health; 2023 Apr; 169(2):176-180. PubMed ID: 33257520
    [TBL] [Abstract][Full Text] [Related]  

  • 76. SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe.
    SCORE2 working group and ESC Cardiovascular risk collaboration
    Eur Heart J; 2021 Jul; 42(25):2439-2454. PubMed ID: 34120177
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Framingham ten-year general cardiovascular disease risk: agreement between BMI-based and cholesterol-based estimates in a South Asian convenience sample.
    Jones CA; Ross L; Surani N; Dharamshi N; Karmali K
    PLoS One; 2015; 10(3):e0119183. PubMed ID: 25781949
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Use of Repeated Blood Pressure and Cholesterol Measurements to Improve Cardiovascular Disease Risk Prediction: An Individual-Participant-Data Meta-Analysis.
    Paige E; Barrett J; Pennells L; Sweeting M; Willeit P; Di Angelantonio E; Gudnason V; Nordestgaard BG; Psaty BM; Goldbourt U; Best LG; Assmann G; Salonen JT; Nietert PJ; Verschuren WMM; Brunner EJ; Kronmal RA; Salomaa V; Bakker SJL; Dagenais GR; Sato S; Jansson JH; Willeit J; Onat A; de la Cámara AG; Roussel R; Völzke H; Dankner R; Tipping RW; Meade TW; Donfrancesco C; Kuller LH; Peters A; Gallacher J; Kromhout D; Iso H; Knuiman M; Casiglia E; Kavousi M; Palmieri L; Sundström J; Davis BR; Njølstad I; Couper D; Danesh J; Thompson SG; Wood A
    Am J Epidemiol; 2017 Oct; 186(8):899-907. PubMed ID: 28549073
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Laboratory-based and office-based Globorisk scores to predict 10-year risk of cardiovascular diseases among Iranians: results from the Fasa PERSIAN cohort.
    Jahangiry L; Dehghan A; Farjam M; Aune D; Rezaei F
    BMC Med Res Methodol; 2022 Nov; 22(1):305. PubMed ID: 36435774
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Prediction of individualized lifetime benefit from cholesterol lowering, blood pressure lowering, antithrombotic therapy, and smoking cessation in apparently healthy people.
    Jaspers NEM; Blaha MJ; Matsushita K; van der Schouw YT; Wareham NJ; Khaw KT; Geisel MH; Lehmann N; Erbel R; Jöckel KH; van der Graaf Y; Verschuren WMM; Boer JMA; Nambi V; Visseren FLJ; Dorresteijn JAN
    Eur Heart J; 2020 Mar; 41(11):1190-1199. PubMed ID: 31102402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.